A Pilot Study of Sirolimus in Subjects with Cowden Syndrome or Other Syndromes Characterized by Germline Mutations in PTEN

LESSONS LEARNED. This is the first human interventional study in patients with Cowden syndrome that is driven by inactivation of germline PTEN gene. Single‐agent sirolimus, a mTOR inhibitor, suppressed mTOR signaling in surrogate human tissues without significant toxicity. BACKGROUND. Cowden syndrom...

Full description

Saved in:
Bibliographic Details
Published in:Oncologist
Main Authors: Komiya, Takefumi, Blumenthal, Gideon M., DeChowdhury, Roopa, Fioravanti, Susan, Ballas, Marc S., Morris, John, Hornyak, Thomas J., Wank, Stephen, Hewitt, Stephen M., Morrow, Betsy, Memmott, Regan M., Rajan, Arun, Dennis, Phillip A.
Format: Artigo
Language:Inglês
Published: John Wiley & Sons, Inc. 2019
Subjects:
Clinical Trial Results
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC6975943/
https://ncbi.nlm.nih.gov/pubmed/31350329
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1634/theoncologist.2019-0514
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items